指南与共识儿科与产科急症呼吸衰竭与机械通气

PCV10对巴西儿童肺炎球菌疾病负担的影响:是时候更新推荐了吗?

Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?
指南 / 共识 · J Pediatr (Rio J) · 2022-12-07
一句话结论PCV10自2010年在巴西显著降低儿童侵袭性肺炎球菌疾病负担,但血清型替换(19A占<5岁IPD的28.2%-44.6%)持续削弱其效果,作者认为更广谱PCV可提供扩展保护。

本文为叙述性综述,检索英文、西班牙文、葡萄牙文文献及巴西流行病学监测数据库,描述2010年PCV10引入后对儿童肺炎球菌感染、携带、血清型替换及抗菌耐药的影响。PCV10使用早期,目标年龄组及部分非目标年龄组全因肺炎住院率下降;实验室确诊肺炎球菌脑膜炎和住院IPD儿童的历史系列研究显示疾病负担、院内病死率及ICU入住受到显著影响。疫苗后期高价青霉素不敏感肺炎球菌显著且进行性增加,2014年起19A血清型在所有年龄组居首,占5岁以下儿童IPD的28.2%-44.6%。作者认为,若将更广谱PCV纳入巴西国家免疫规划,可对19A及其他日益重要的血清型提供扩展的直接和间接保护。

要点

  • PCV10使用早期,目标年龄组及部分非目标年龄组全因肺炎住院率下降。
  • 实验室确诊肺炎球菌脑膜炎和住院IPD儿童的历史系列研究显示,疫苗引入前后疾病负担、院内病死率和ICU入住受到显著影响。
  • 疫苗后期高价青霉素不敏感肺炎球菌显著且进行性增加。
  • 2014年起19A血清型在所有年龄组居首,占5岁以下儿童IPD的28.2%-44.6%。
  • 中耳炎影响数据有限且不一致,主要获益仍为预防复杂性疾病。

适用人群与场景

  • 巴西儿童,包括PCV10接种目标年龄组及部分非目标年龄组。

研究设计与关键结果

  • 叙述性综述,检索英文、西班牙文、葡萄牙文在线数据库文献及巴西流行病学监测数据库,关键词包括肺炎链球菌、肺炎球菌疾病、结合疫苗、PCV10、抗菌耐药和脑膜炎。
  • PCV10使用早期,目标年龄组及部分非目标年龄组全因肺炎住院率下降。
  • 实验室确诊肺炎球菌脑膜炎的大型描述性研究和住院IPD儿童的历史系列研究显示,疫苗引入前后疾病负担、院内病死率和ICU入住受到显著影响。
  • 中耳炎影响数据有限且不一致,主要获益仍为预防复杂性疾病。
  • 疫苗后期高价青霉素不敏感肺炎球菌显著且进行性增加。
  • 2014年起19A血清型在所有年龄组居首,占5岁以下儿童IPD的28.2%-44.6%。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,PCV10自2010年以来对巴西IPD产生显著影响,但进展持续受血清型替换阻碍。
  • 作者认为,若将更广谱PCV纳入巴西国家免疫规划并给予儿童,可对19A及其他日益重要的血清型提供扩展的直接和间接保护。

指南或共识出处

  • J Pediatr (Rio J) 发表的叙述性综述《Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?》

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To describe the impact of the 10-valent pneumococcal conjugate vaccine on the pediatric burden of pneumococcal infections, carriage, serotype replacement, and antimicrobial resistance in Brazil since its introduction in 2010.

DATA SOURCE: A narrative review of English, Spanish, and Portuguese articles published in online databases and in Brazilian epidemiological surveillance databases was performed. The following keywords were used: Streptococcus pneumoniae, pneumococcal disease, conjugate vaccine, PCV10, antimicrobial resistance, and meningitis.

SUMMARY OF THE FINDINGS: Declines in hospitalization rates of all-cause pneumonia occurred in the target age groups and some age groups not targeted by vaccination early after the use of PCV10. Large descriptive studies of laboratory-confirmed pneumococcal meningitis and hospital-based historical series of hospitalized children with IPD have evidenced a significant impact on disease burden, in-hospital fatality rates, and admission to the intensive care unit before and after the inclusion of the vaccine. Impact data on otitis media is limited and inconsistent; the main benefit remains the prevention of complicated diseases. During the late post-vaccine years, a significant and progressive increase in high-level penicillin non-susceptibility pneumococci has been described. Since 2014 serotype 19A has been the leading serotype in all ages and was responsible for 28.2%-44.6% of all IPD in children under 5 yrs.

CONCLUSIONS: PCV10 has performed a significant impact on IPD in Brazil since 2010, however, progress has been continuously hampered by replacement. Broader spectrum PCVs could provide expanded direct and indirect protection against ST19A and other additional serotypes of increasing importance if administered to children in the Brazilian National Immunization Program.

来源:J Pediatr (Rio J),查看原文。版权归原作者所有。

参考来源

  1. Jarovsky D, Berezin EN. Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations? J Pediatr (Rio J). 2022. PMID: 36495946. doi:10.1016/j.jped.2022.11.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。